Vanrx closed robotic workcells eliminate human interventions in the aseptic process and prevent operators from being exposed to dangerous substances.

Aseptic filling technology for cytotoxic drug products.

Vanrx’s Aseptic Filling Workcells were made for keeping potent drug products in the box. Closed robotic workcells eliminate human interventions in the aseptic process and prevent operators from being exposed to dangerous substances.

Who uses Vanrx aseptic filling machines?

Leading biopharma companies using Vanrx Aseptic Filling Workcells include ADMA Biologics, Amgen, Emergent BioSolutions, FUJIFILM Diosynth Biotechnologies, Roche / Genentech, Moderna, Singota Solutions, WuXi Biologics, and Wildlife Pharmaceuticals.

Vanrx aseptic filling workcells were designed around the ideas of containment and production efficiency.

Complete process design for cytotoxic containment

In leading manufacturing operations, Vanrx’s founders spent considerable time filling cytotoxic and potent compounds. Our systems were designed around these needs, including the fully integrated design of a robotic process within a gloveless isolator. Every part of the design contributes to containment and production efficiency:

  • Robotic container handling and filling
  • Single-use consumables
  • Quick-change ultra-low particulate filters
  • Automated clean-in-place

Risks to operator exposure / loss of containment and drug product quality are reduced to a minimum. We have the data to prove it.

Vanrx workcells can be used for both liquid and lyophilized filling.

Flexibility for liquid or lyophilized drug products

The SA25 Aseptic Filling Workcell allows liquid filling into vials, syringes or cartridges. Scaling up to the Vanrx Liquid / Lyo Workcell System allows for liquid filling, then automated loading and unloading from a lyophilizer. And the SA25 can be used for liquid doses while lyophilization cycles are underway.

Vanrx systems are standardized, allowing you to bring drug products to patients faster.

Speed to market

Vanrx systems are standardized, allowing you to bring drug products to patients faster. You won’t have to design a new aseptic process or combination of isolator and filling machinery. We’ve done the work. With fast lead times, you could have an SA25 built and validated in a year, while the same goals for the Liquid / Lyo Workcell System can be achieved in 18 months. We can work with any of the major lyophilizer manufacturers.